We canât show the full text here under this license. Use the link below to read it at the source.
RETRACTED: Polycomb repressive complex 2 binds and stabilizes NANOG to suppress differentiation-related genes to promote self-renewal
Polycomb repressive complex 2 supports stem cell renewal by stabilizing NANOG and blocking differentiation genes
AI simplified
Abstract
The interaction between PRC2 and NANOG may serve as a new drug target for hepatocellular carcinoma (HCC).
- Alcohol and HCV activate NANOG through TLR4 signaling, which is important for the development of tumor-initiating stem-like cells.
- NANOG, along with the PRC2 complex, inhibits genes involved in energy production to support the growth of these cancer cells.
- NANOG protein stability is enhanced by its binding to EED, preventing its degradation.
- Loss of the human ARID1A gene may lead to resistance against therapies targeting fatty acid oxidation and PRC2.
- In mouse models of HCC, disrupting the PRC2-NANOG interaction or inhibiting fatty acid oxidation effectively halted tumor growth.
AI simplified